P Bourdon

2.0k total citations · 1 hit paper
14 papers, 1.6k citations indexed

About

P Bourdon is a scholar working on Oncology, Hematology and Cancer Research. According to data from OpenAlex, P Bourdon has authored 14 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Hematology and 5 papers in Cancer Research. Recurrent topics in P Bourdon's work include Peptidase Inhibition and Analysis (5 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Protease and Inhibitor Mechanisms (4 papers). P Bourdon is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Protease and Inhibitor Mechanisms (4 papers). P Bourdon collaborates with scholars based in United States, Switzerland and Sweden. P Bourdon's co-authors include John M. Maraganore, Jeffrey L. Browning, John W. Fenton, Catherine Hession, K L Ramachandran, Yen‐Ming Hsu, Yves Chicheportiche, Haoda Xu, Hamish S. Scott and Irène Garcia and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

P Bourdon

14 papers receiving 1.6k citations

Hit Papers

TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor... 1997 2026 2006 2016 1997 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Bourdon United States 13 576 533 444 401 267 14 1.6k
Robin A. Pixley United States 26 592 1.0× 493 0.9× 241 0.5× 1.2k 2.9× 105 0.4× 53 2.3k
Denuja Karunakaran Canada 17 502 0.9× 814 1.5× 420 0.9× 381 1.0× 257 1.0× 30 1.6k
Markus A. Riederer Switzerland 19 395 0.7× 1.0k 1.9× 138 0.3× 1.3k 3.2× 315 1.2× 34 3.0k
Susan H. Tam United States 19 448 0.8× 784 1.5× 112 0.3× 238 0.6× 202 0.8× 32 1.6k
Klaus Preissner Germany 17 200 0.3× 376 0.7× 136 0.3× 300 0.7× 110 0.4× 26 1.1k
Linda M.S. Fritze United States 16 113 0.2× 840 1.6× 295 0.7× 359 0.9× 163 0.6× 20 1.7k
Renren Wen United States 31 1.7k 2.9× 873 1.6× 454 1.0× 358 0.9× 338 1.3× 75 2.8k
Keith E. Norman United Kingdom 17 790 1.4× 419 0.8× 122 0.3× 355 0.9× 76 0.3× 36 1.6k
Lacramioara Ivanciu United States 17 324 0.6× 456 0.9× 66 0.1× 497 1.2× 114 0.4× 31 1.3k
Gigliola Reato Italy 18 262 0.5× 484 0.9× 262 0.6× 96 0.2× 86 0.3× 36 1.4k

Countries citing papers authored by P Bourdon

Since Specialization
Citations

This map shows the geographic impact of P Bourdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Bourdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Bourdon more than expected).

Fields of papers citing papers by P Bourdon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Bourdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Bourdon. The network helps show where P Bourdon may publish in the future.

Co-authorship network of co-authors of P Bourdon

This figure shows the co-authorship network connecting the top 25 collaborators of P Bourdon. A scholar is included among the top collaborators of P Bourdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Bourdon. P Bourdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Rich, Jonathan D., John M. Maraganore, Edward Young, et al.. (2007). Heparin resistance in acute coronary syndromes. Journal of Thrombosis and Thrombolysis. 23(2). 93–100. 12 indexed citations
2.
Mackay, Fabienne, P Bourdon, David Griffiths, et al.. (1997). Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes. The Journal of Immunology. 159(7). 3299–3310. 37 indexed citations
3.
Browning, Jeffrey L., Irene Sizing, P Bourdon, et al.. (1997). Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. The Journal of Immunology. 159(7). 3288–3298. 161 indexed citations
4.
Chicheportiche, Yves, P Bourdon, Haoda Xu, et al.. (1997). TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis. Journal of Biological Chemistry. 272(51). 32401–32410. 563 indexed citations breakdown →
5.
Browning, Jeffrey L., Konrad Miatkowski, David Griffiths, et al.. (1996). Preparation and Characterization of Soluble Recombinant Heterotrimeric Complexes of Human Lymphotoxins and. Journal of Biological Chemistry. 271(15). 8618–8626. 37 indexed citations
6.
Browning, Jeffrey L., Irene Dougas, Apinya Ngam-ek, et al.. (1995). Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.. The Journal of Immunology. 154(1). 33–46. 136 indexed citations
7.
Bourdon, P, et al.. (1992). Thrombin-specific inhibition by and slow cleavage of hirulog-1. Biochemical Journal. 283(3). 737–743. 85 indexed citations
8.
Kelly, Adrian B., John M. Maraganore, P Bourdon, Stephen R. Hanson, & LA Harker. (1992). Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin.. Proceedings of the National Academy of Sciences. 89(13). 6040–6044. 60 indexed citations
9.
Kline, Toni, Charles E. Hammond, P Bourdon, & John M. Maraganore. (1991). Hirulog peptides with scissile bond replacements resistant to thrombin cleavage. Biochemical and Biophysical Research Communications. 177(3). 1049–1055. 36 indexed citations
10.
Bourdon, P, et al.. (1991). Structure‐function relationships of hirulog peptide interactions with thrombin. FEBS Letters. 294(3). 163–166. 19 indexed citations
11.
Maraganore, John M., et al.. (1990). Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry. 29(30). 7095–7101. 380 indexed citations
12.
Bourdon, P, John W. Fenton, & John M. Maraganore. (1990). Affinity labeling of lysine-149 in the anion-binding exosite of human .alpha.-thrombin with an N.alpha.-(dinitrofluorobenzyl)hirudin C-terminal peptide. Biochemistry. 29(27). 6379–6384. 22 indexed citations
13.
Ohlin, A K, Gregory M. Landes, P Bourdon, et al.. (1988). Beta-hydroxyaspartic acid in the first epidermal growth factor-like domain of protein C. Its role in Ca2+ binding and biological activity.. Journal of Biological Chemistry. 263(35). 19240–19248. 89 indexed citations
14.
Bourdon, P, et al.. (1979). Studies of perfume solubilisation. International Journal of Cosmetic Science. 1(1). 1–15. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026